NCT01900704View on ClinicalTrials.gov

Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4

PHASE3CompletedINTERVENTIONAL
Enrollment

810

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Nocturia
Interventions
DRUG

SER120 750 ng

SER120 750 ng

DRUG

SER120 1500 ng

SER120 1500 ng

DRUG

Placebo

Placebo

Trial Locations (1)

92660

Stephen M. Auerbach, MD, Newport Beach

All Listed Sponsors
lead

Serenity Pharmaceuticals, Inc.

INDUSTRY

NCT01900704 - Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4 | Biotech Hunter | Biotech Hunter